iXensor Co., Ltd. announced that it has received funding on April 27, 2022. The transaction included participation from new investor Rohto Pharmaceutical Co.,Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.08 TWD | -0.39% | -2.50% | -39.23% |
May. 03 | IXensor Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | IXensor Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-39.23% | 8.57M | |
+2.24% | 205B | |
+6.45% | 179B | |
+31.46% | 158B | |
+33.00% | 113B | |
+4.87% | 64.93B | |
+21.77% | 56.51B | |
-2.92% | 46.36B | |
-5.91% | 37.07B | |
+3.39% | 36.12B |
- Stock Market
- Equities
- 6734 Stock
- News iXensor Co., Ltd.
- IXensor Co., Ltd. announced that it has received funding from Rohto Pharmaceutical Co.,Ltd.